9,900
Participants
Start Date
March 26, 2024
Primary Completion Date
April 1, 2026
Study Completion Date
April 1, 2026
Standard intervention: Offer PrEP choice
This hybrid observational-implementation study will observe the implementation of a choice of oral pre-exposure prophylaxis or long-acting injectable cabotegravir for pre-exposure prophylaxis for all participants.
RECRUITING
Community Health Science Unit, Lilongwe
Collaborators (3)
AIDS Vaccine Advocacy Coalition
UNKNOWN
Centers for Disease Control and Prevention
FED
Center for the Development of People
UNKNOWN
Cooper/Smith
UNKNOWN
Elizabeth Glaser Pediatric AIDS Foundation
OTHER
Family Health Services
UNKNOWN
Healthqual
UNKNOWN
Johns Hopkins Research Project, Malawi
UNKNOWN
Johns Hopkins Bloomberg School of Public Health
OTHER
Kamuzu University of Health Sciences
OTHER
Blantyre District Health Office, Malawi
UNKNOWN
Lilongwe District Health Office, Malawi
UNKNOWN
Lighthouse Trust
OTHER
Ministry of Health, Malawi
OTHER_GOV
National AIDS Commission, Malawi
UNKNOWN
Pakachere Institute of Health and Development Communication
UNKNOWN
Partners in Hope, Inc.
INDUSTRY
Population Services International
OTHER
University of North Carolina
OTHER
United States Agency for International Development (USAID)
FED
United States President's Emergency Plan for AIDS Relief
FED
Quantitative Engineering Design
UNKNOWN
Clinton Health Access Initiative-Malawi
UNKNOWN
Georgetown University
OTHER